AKT1 and cancer: This study provides the first evidence that pharmacological concentrations of VC induce the expression of pro-apoptotic proteins such as Apaf-1 and caspases -7 and -9, while inhibiting cancer cell survival proteins like Bcl-2, cyclins D and B1, CDK2, Akt, pI3K, and mTOR.